Stephen D. Griffin's most recent trade in Anika Therapeutics Inc. was a trade of 12,840 Restricted Stock Unit done . Disclosure was reported to the exchange on June 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anika Therapeutics Inc | Stephen D. Griffin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 12,840 | 12,840 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc | Stephen D. Griffin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 12,840 | 49,742 (0%) | 0% | - | Common Stock | |
| Anika Therapeutics Inc | Stephen D. Griffin | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.41 per share. | 03 Jun 2026 | 3,769 | 45,973 (0%) | 0% | 14.4 | 54,311 | Common Stock |
| Anika Therapeutics Inc | Stephen D. Griffin | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 12.29 per share. | 30 Apr 2026 | 12,200 | 36,163 (0%) | 0% | 12.3 | 149,881 | Common Stock |
| Anika Therapeutics Inc | Stephen D. Griffin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2026 | 12,824 | 23,495 (0%) | 0% | - | Common Stock | |
| Anika Therapeutics Inc | Stephen D. Griffin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2026 | 12,824 | 25,649 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc | Stephen D. Griffin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2026 | 6,412 | 29,907 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc | Stephen D. Griffin | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.20 per share. | 14 Mar 2026 | 5,944 | 23,963 (0%) | 0% | 14.2 | 84,405 | Common Stock |
| Anika Therapeutics Inc | Stephen D. Griffin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 310,207 | 310,207 | - | - | Stock Appreciation Rights | |
| Anika Therapeutics Inc | Stephen D. Griffin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 130,402 | 130,402 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc | Stephen D. Griffin | EVP, CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 12,840 | 25,680 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc | Stephen D. Griffin | EVP, CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 12,840 | 13,640 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc | Stephen D. Griffin | EVP, CFO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.59 per share. | 03 Jun 2025 | 3,769 | 9,871 (0%) | 0% | 11.6 | 43,683 | Common Stock |
| Anika Therapeutics Inc | Stephen D. Griffin | EVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 38,473 | 38,473 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc | Stephen D. Griffin | EVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 18,672 | 18,672 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc | Stephen D. Griffin | EVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 96,525 | 96,525 | - | - | Stock Option (Right to Buy) | |
| Anika Therapeutics Inc | Stephen D. Griffin | EVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 38,520 | 38,520 | - | - | Restricted Stock Unit | |
| VSE Corp | Stephen D. Griffin | Senior Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 2,567 | 28,636 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| VSE Corp | Stephen D. Griffin | Senior Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 1,287 | 29,923 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| VSE Corp | Stephen D. Griffin | Senior Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.02 per share. | 31 Mar 2024 | 1,160 | 28,763 (0%) | 0% | 79.0 | 91,663 | Common Stock, par value $.05 |
| VSE Corp | Stephen D. Griffin | Senior Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 5,132 | 25,955 (0%) | 0% | 0 | Common Stock | |
| VSE Corp | Stephen D. Griffin | Senior Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 3,549 | 3,549 | - | - | Restricted Stock Units | |
| VSE Corp | Stephen D. Griffin | Senior Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.12 per share. | 08 Mar 2024 | 3,031 | 26,069 (0%) | 0% | 75.1 | 227,689 | Common Stock |
| VSE Corp | Stephen D. Griffin | Senior Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 1,832 | 20,823 (0%) | 0% | - | Common Stock | |
| VSE Corp | Stephen D. Griffin | Senior Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 1,832 | 3,666 | - | - | Restricted Stock Units | |
| VSE Corp | Stephen D. Griffin | Senior Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 1,821 | 29,100 (0%) | 0% | 0 | Common Stock | |
| VSE Corp | Stephen D. Griffin | Senior Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 1,324 | 1,324 | - | - | Restricted Stock Units | |
| VSE Corp | Stephen D. Griffin | Senior Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 1,324 | 27,279 (0%) | 0% | - | Common Stock | |
| VSE Corp | Stephen D. Griffin | Senior Vice President and CFO | Grant, award, or other acquisition of securities at price $ 47.12 per share. | 29 Dec 2023 | 233 | 18,991 (0%) | 0% | 47.1 | 10,978 | Common Stock, par value $.05 |
| VSE Corp | Stephen D. Griffin | Senior Vice President and CFO | Grant, award, or other acquisition of securities at price $ 41.01 per share. | 30 Jun 2023 | 268 | 18,758 (0%) | 0% | 41.0 | 10,990 | Common Stock, par value $.05 |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 1,416 | 19,304 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 1,288 | 17,888 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.90 per share. | 31 Mar 2023 | 814 | 18,490 (0%) | 0% | 44.9 | 36,549 | Common Stock, par value $.05 |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 5,498 | 5,498 | - | - | Restricted Stock Units | |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 1,820 | 17,547 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 1,324 | 15,727 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.95 per share. | 10 Mar 2023 | 947 | 16,600 (0%) | 0% | 41.0 | 38,780 | Common Stock, par value $.05 |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 66 | 14,423 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.25 per share. | 10 Mar 2023 | 20 | 14,403 (0%) | 0% | 42.3 | 845 | Common Stock, par value $.05 |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Grant, award, or other acquisition of securities at price $ 32.31 per share. | 30 Dec 2022 | 141 | 14,357 (0%) | 0% | 32.3 | 4,556 | Common Stock, par value $.05 |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 5,000 | 15,722 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.54 per share. | 09 Nov 2022 | 1,506 | 14,216 (0%) | 0% | 48.5 | 73,101 | Common Stock, par value $.05 |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Grant, award, or other acquisition of securities at price $ 33.07 per share. | 30 Jun 2022 | 323 | 10,722 (0%) | 0% | 33.1 | 10,682 | Common Stock, par value $.05 |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 1,328 | 11,176 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2022 | 1,288 | 9,848 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.09 per share. | 31 Mar 2022 | 777 | 10,399 (0%) | 0% | 46.1 | 35,812 | Common Stock, par value $.05 |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 3,972 | 3,972 | - | - | Restricted Stock Units | |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 64 | 8,579 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.32 per share. | 11 Mar 2022 | 19 | 8,560 (0%) | 0% | 43.3 | 823 | Common Stock, par value $.05 |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Grant, award, or other acquisition of securities at price $ 44.04 per share. | 31 Dec 2021 | 204 | 8,515 (0%) | 0% | 44.0 | 8,984 | Common Stock, par value $.05 |
| VSE Corp | Stephen D. Griffin | Sr. VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2021 | 5,000 | 8,311 (0%) | 0% | 0 | Common Stock, par value $.05 |